An innovative robotic architecture delivers superior throughput for automated IHC & ISH staining and provides diagnosis up to 50 percent faster than previous generation stainers.

Breakthrough platform technology enables researchers to more effectively develop and automate new cell-based therapies.

This next generation instrument brought the client’s breakthrough technology from the clinical lab to the point of care for life-saving results.

This equipment automatically picks plantlets from agar-gel trays, sections them using machine vision to identify the right cutting points, and replants the sections in new trays.

This facial cleansing brush redefined the market with breakthrough technology and a focus on user experience.

RoboSep® is the world’s first fully automated cell separator.

Partnered mid-development to deliver high precision sampling subsystem solutions for new Point of Care immunoassay analyzer.

Next-generation fountain dispensers changed the game by delivering an unprecedented variety of beverage choices using technology initially developed for the medical industry.

Organovo turned science fiction into science fact with the world’s first commercial 3D bioprinter to print human tissues.

Evolved existing technology into a highly usable, robust, market-ready general-purpose sample preparation instrument in just 20 months.

We provided turnkey instrument development and contract manufacture for a fully automated immunoassay instrument capable of up to 2200 results per hour.

A revolutionary biomarker analysis platform realizing next-generation personalized healthcare.